{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:51:44Z","timestamp":1783529504405,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH120227"],"award-info":[{"award-number":["R01MH120227"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH131687"],"award-info":[{"award-number":["R01MH131687"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH120227"],"award-info":[{"award-number":["R01MH120227"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH131687"],"award-info":[{"award-number":["R01MH131687"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Microglia dysregulation is implicated across a range of neurodevelopmental and neurodegenerative disorders, making their modulation a promising therapeutic target. Using PBMC-derived induced microglia-like cells (piMGLCs) in a scalable assay, we screened 489 CNS-penetrant compounds for modulation of microglial phagocytosis of human synaptosomes in a validated assay for microglia-mediated synaptic pruning. Compounds from the library that reduced phagocytosis by \u22652 standard deviations across the library without cytotoxicity were validated in secondary screens, with 28 of them further confirmed to reduce phagocytosis by 50% or more. These compounds comprise a wide range of therapeutic classes with different mechanisms of action, including immunosuppressants, kinase inhibitors, antipsychotics, and epigenetic modulators. Image-based morphological measurements were calculated to measure the degree of ramified vs. ameboid morphotypes as an indicator of activation state. Additionally, transcriptomic profiling indicated divergent effects on cell signaling, metabolism, activation, and actin dynamics across confirmed compounds. In particular, multiple CNS-penetrant small molecules with prior FDA approval or demonstration of safety in vivo demonstrated modulatory effects on microglia. For example, identified drugs such as the tyrosine kinase inhibitors lapatinib, alectinib, and lazertinib and the epigenetic modulator vorinostat have been approved for various cancer treatments and are being investigated for other indications; however, they have not been extensively studied in patients for neurodevelopmental and neurodegenerative disorders. These potential disease-modifying agents represent high-priority candidates for repositioning studies in neurodevelopmental, neuroinflammatory, or neurodegenerative disorders.<\/jats:p>","DOI":"10.1038\/s41386-025-02123-1","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T14:12:40Z","timestamp":1746799960000},"page":"1544-1552","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identifying brain-penetrant small-molecule modulators of human microglia using a cellular model of synaptic pruning"],"prefix":"10.1038","volume":"50","author":[{"given":"Liam T.","family":"McCrea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Batorsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-5361","authenticated-orcid":false,"given":"Jessica M.","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5862-6757","authenticated-orcid":false,"given":"Roy H.","family":"Perlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-1158","authenticated-orcid":false,"given":"Steven D.","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"2123_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2017.01.002","volume":"149","author":"C-A Mosser","year":"2017","unstructured":"Mosser C-A, Baptista S, Arnoux I, Audinat E. Microglia in CNS development: shaping the brain for the future. Prog Neurobiol. 2017;149:1\u201320.","journal-title":"Prog Neurobiol"},{"key":"2123_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052358.","journal-title":"Annu Rev Immunol"},{"key":"2123_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/cne.21123","volume":"499","author":"A Monier","year":"2006","unstructured":"Monier A, Evrard P, Gressens P, Verney C. Distribution and differentiation of microglia in the human encephalon during the first two trimesters of gestation. J Comp Neurol. 2006;499:565\u201382. https:\/\/doi.org\/10.1002\/cne.21123","journal-title":"J Comp Neurol"},{"key":"2123_CR4","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308:1314\u20138. https:\/\/doi.org\/10.1126\/science.1110647","journal-title":"Science"},{"key":"2123_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250232","volume":"53","author":"P Petry","year":"2023","unstructured":"Petry P, Oschwald A, Kierdorf K. Microglial tissue surveillance: the never-resting gardener in the developing and adult CNS. Eur J Immunol. 2023;53:2250232 https:\/\/doi.org\/10.1002\/eji.202250232","journal-title":"Eur J Immunol"},{"key":"2123_CR6","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1523\/JNEUROSCI.3441-12.2013","volume":"33","author":"CL Cunningham","year":"2013","unstructured":"Cunningham CL, Mart\u00ednez-Cerde\u00f1o V, Noctor SC. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci. 2013;33:4216\u201333.","journal-title":"J Neurosci"},{"key":"2123_CR7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/glia.22858","volume":"63","author":"K Sato","year":"2015","unstructured":"Sato K. Effects of microglia on neurogenesis. Glia. 2015;63:1394\u2013405.","journal-title":"Glia"},{"key":"2123_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/brainsci11050658","volume":"11","author":"DR P\u00e9rez-Rodr\u00edguez","year":"2021","unstructured":"P\u00e9rez-Rodr\u00edguez DR, Blanco-Luquin I, Mendioroz M. The participation of microglia in neurogenesis: a review. Brain Sci. 2021;11:658.","journal-title":"Brain Sci"},{"key":"2123_CR9","doi-asserted-by":"publisher","first-page":"e1000527","DOI":"10.1371\/journal.pbio.1000527","volume":"8","author":"M-\u00c8 Tremblay","year":"2010","unstructured":"Tremblay M-\u00c8, Lowery RL, Majewska AK. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010;8:e1000527.","journal-title":"PLoS Biol"},{"key":"2123_CR10","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456\u20138. https:\/\/doi.org\/10.1126\/science.1202529","journal-title":"Science"},{"key":"2123_CR11","doi-asserted-by":"crossref","unstructured":"Faust TE, Gunner G, Schafer DP. Mechanisms governing activity-dependent synaptic pruning in the developing mammalian CNS. Nat Rev Neurosci. 2021;22:657\u201373.","DOI":"10.1038\/s41583-021-00507-y"},{"key":"2123_CR12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nrn.2017.110","volume":"18","author":"U Neniskyte","year":"2017","unstructured":"Neniskyte U, Gross CT. Errant gardeners: glial-cell-dependent synaptic pruning and neurodevelopmental disorders. Nat Rev Neurosci. 2017;18:658\u201370. https:\/\/doi.org\/10.1038\/nrn.2017.110","journal-title":"Nat Rev Neurosci"},{"key":"2123_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/YCO.0000000000000696","volume":"34","author":"M Germann","year":"2021","unstructured":"Germann M, Brederoo SG, Sommer IE. Abnormal synaptic pruning during adolescence underlying the development of psychotic disorders. Curr Opin Psychiatry. 2021;34:222\u20137.","journal-title":"Curr Opin Psychiatry"},{"key":"2123_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","volume":"22","author":"CM Sellgren","year":"2019","unstructured":"Sellgren CM, Gracias J, Watmuff B, Biag JD, Thanos JM, Whittredge PB, et al. Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat Neurosci. 2019;22:374\u201385. https:\/\/doi.org\/10.1038\/s41593-018-0334-7","journal-title":"Nat Neurosci"},{"key":"2123_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neuroscience.2012.04.044","volume":"251","author":"JR Glausier","year":"2013","unstructured":"Glausier JR, Lewis DA. Dendritic spine pathology in schizophrenia. Neuroscience. 2013;251:90\u2013107. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.04.044","journal-title":"Neuroscience"},{"key":"2123_CR16","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/jamapsychiatry.2014.1582","volume":"71","author":"GT Konopaske","year":"2014","unstructured":"Konopaske GT, Lange N, Coyle JT, Benes FM. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry. 2014;71:1323\u201331. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1582","journal-title":"JAMA Psychiatry"},{"key":"2123_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","volume":"57","author":"LA Glantz","year":"2000","unstructured":"Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000;57:65\u201373. https:\/\/doi.org\/10.1001\/archpsyc.57.1.65","journal-title":"Arch Gen Psychiatry"},{"key":"2123_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","volume":"173","author":"PS Bloomfield","year":"2016","unstructured":"Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR, et al. Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [11C] PBR28 PET brain imaging study. Am J Psychiatry. 2016;173:44\u201352.","journal-title":"Am J Psychiatry"},{"key":"2123_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.biopsych.2014.05.023","volume":"77","author":"TD Cannon","year":"2015","unstructured":"Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. 2015;77:147\u201357. https:\/\/doi.org\/10.1016\/j.biopsych.2014.05.023","journal-title":"Biol Psychiatry"},{"key":"2123_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177\u201383. https:\/\/doi.org\/10.1038\/nature16549","journal-title":"Nature"},{"key":"2123_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fnmol.2017.00421","volume":"10","author":"TL Tay","year":"2018","unstructured":"Tay TL, B\u00e9chade C, D\u2019andrea I, St-Pierre M-K, Henry MS, Roumier A, et al. Microglia gone rogue: impacts on psychiatric disorders across the lifespan. Front Mol Neurosci. 2018;10:421.","journal-title":"Front Mol Neurosci"},{"key":"2123_CR22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14:388\u2013405.","journal-title":"Lancet Neurol"},{"key":"2123_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1117172","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Zong S, Cui X, Wang X, Wu S, Wang L, et al. The effects of microglia-associated neuroinflammation on Alzheimer\u2019s disease. Front Immunol. 2023;14:1117172.","journal-title":"Front Immunol"},{"key":"2123_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"2123_CR25","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1017\/S0033291719001995","volume":"49","author":"N \u00c7akici","year":"2019","unstructured":"\u00c7akici N, van Beveren NJM, Judge-Hundal G, Koola MM, Sommer IEC. An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis. Psychol Med. 2019;49:2307\u201319. https:\/\/doi.org\/10.1017\/S0033291719001995","journal-title":"Psychol Med"},{"key":"2123_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1333717","volume":"15","author":"H Jyonouchi","year":"2024","unstructured":"Jyonouchi H. Autism spectrum disorder and a possible role of anti-inflammatory treatments: experience in the pediatric allergy\/immunology clinic. Front Psychiatry. 2024;15:1333717.","journal-title":"Front Psychiatry"},{"key":"2123_CR27","doi-asserted-by":"crossref","unstructured":"Sheridan SD, Horng JE, Perlis RH. Patient-derived in vitro models of microglial function and synaptic engulfment in schizophrenia. Biol Psychiatry. 2022;92:470\u20139.","DOI":"10.1016\/j.biopsych.2022.01.004"},{"key":"2123_CR28","doi-asserted-by":"publisher","unstructured":"Banerjee A, Lu Y, Do K, Mize T, Wu X, Chen X, et al. Validation of induced microglia-like cells (iMG Cells) for future studies of brain diseases. Front Cell Neurosci. 2021. https:\/\/doi.org\/10.3389\/fncel.2021.629279","DOI":"10.3389\/fncel.2021.629279"},{"key":"2123_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai7635","volume":"9","author":"KJ Ryan","year":"2017","unstructured":"Ryan KJ, White CC, Patel K, Xu J, Olah M, Replogle JM, et al. A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. Sci Transl Med. 2017;9:eaai7635 https:\/\/doi.org\/10.1126\/scitranslmed.aai7635","journal-title":"Sci Transl Med"},{"key":"2123_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/mp.2016.220","volume":"22","author":"C Sellgren","year":"2017","unstructured":"Sellgren C, Sheridan S, Gracias J, Xuan D, Fu T, Perlis R. Patient-specific models of microglia-mediated engulfment of synapses and neural progenitors. Mol Psychiatry. 2017;22:170\u2013177.","journal-title":"Mol Psychiatry"},{"key":"2123_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.biopsych.2023.07.022","volume":"95","author":"SD Sheridan","year":"2024","unstructured":"Sheridan SD, Horng JE, Yeh H, McCrea L, Wang J, Fu T, et al. Loss of function in the neurodevelopmental disease and schizophrenia-associated gene CYFIP1 in human microglia-like cells supports a functional role in synaptic engulfment. Biol Psychiatry. 2024;95:676\u201386.","journal-title":"Biol Psychiatry"},{"key":"2123_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling DR, Swain-Bowden MJ, Lucas AM, Carpenter AE, Cimini BA, Goodman A. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinform. 2021;22:433. https:\/\/doi.org\/10.1186\/s12859-021-04344-9","journal-title":"BMC Bioinform"},{"key":"2123_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06500-x","volume":"9","author":"C Ye","year":"2018","unstructured":"Ye C, Ho DJ, Neri M, Yang C, Kulkarni T, Randhawa R, et al. DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery. Nat Commun. 2018;9:4307. https:\/\/doi.org\/10.1038\/s41467-018-06500-x","journal-title":"Nat Commun"},{"key":"2123_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"2123_CR35","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1021\/acschembio.1c00920","volume":"17","author":"J Li","year":"2022","unstructured":"Li J, Ho DJ, Henault M, Yang C, Neri M, Ge R, et al. DRUG-seq provides unbiased biological activity readouts for neuroscience drug discovery. ACS Chem Biol. 2022;17:1401\u201314. https:\/\/doi.org\/10.1021\/acschembio.1c00920","journal-title":"ACS Chem Biol"},{"key":"2123_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1\u201321.","journal-title":"Genome Biol"},{"key":"2123_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, Green J, Pollard Jr J, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523\u201330.","journal-title":"Bioinformatics"},{"key":"2123_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen. 1999;4:67\u201373. https:\/\/doi.org\/10.1177\/108705719900400206","journal-title":"J Biomol Screen"},{"key":"2123_CR39","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1093\/bioinformatics\/btv455","volume":"31","author":"J-P Mpindi","year":"2015","unstructured":"Mpindi J-P, Swapnil P, Dmitrii B, Jani S, Saeed K, Wennerberg K, et al. Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose\u2013response data. Bioinformatics. 2015;31:3815\u201321.","journal-title":"Bioinformatics"},{"key":"2123_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/1087057111405851","volume":"16","author":"XD Zhang","year":"2011","unstructured":"Zhang XD. Illustration of SSMD, z score, SSMD*, z* score, and t statistic for hit selection in RNAi high-throughput screens. SLAS Discov. 2011;16:775\u201385.","journal-title":"SLAS Discov"},{"key":"2123_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.997786","volume":"13","author":"A Vidal-Itriago","year":"2022","unstructured":"Vidal-Itriago A, Radford RA, Aramideh JA, Maurel C, Scherer NM, Don EK, et al. Microglia morphophysiological diversity and its implications for the CNS. Front Immunol. 2022;13:997786.","journal-title":"Front Immunol"},{"key":"2123_CR42","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.STR.32.5.1208","volume":"32","author":"D Ito","year":"2001","unstructured":"Ito D, Tanaka K, Suzuki S, Dembo T, Fukuuchi Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke. 2001;32:1208\u201315. https:\/\/doi.org\/10.1161\/01.STR.32.5.1208","journal-title":"Stroke"},{"key":"2123_CR43","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1348-0421.2000.tb02556.x","volume":"44","author":"I Mori","year":"2000","unstructured":"Mori I, Imai Y, Kohsaka S, Kimura Y. Upregulated expression of Iba1 molecules in the central nervous system of mice in response to neurovirulent influenza A virus infection. Microbiol Immunol. 2000;44:729\u201335.","journal-title":"Microbiol Immunol"},{"key":"2123_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.18240\/ijo.2021.02.04","volume":"14","author":"FJ Shi","year":"2021","unstructured":"Shi FJ, Xie H, Zhang CY, Qin HF, Zeng XW, Lou H, et al. Is Iba-1 protein expression a sensitive marker for microglia activation in experimental diabetic retinopathy? Int J Ophthalmol. 2021;14:200\u20138. https:\/\/doi.org\/10.18240\/ijo.2021.02.04","journal-title":"Int J Ophthalmol"},{"key":"2123_CR45","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1242\/jcs.114.6.1061","volume":"114","author":"RC May","year":"2001","unstructured":"May RC, Machesky LM. Phagocytosis and the actin cytoskeleton. J cell Sci. 2001;114:1061\u201377.","journal-title":"J cell Sci"},{"key":"2123_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1232241","volume":"11","author":"B Ning","year":"2023","unstructured":"Ning B, Hang S, Zhang W, Mao C, Li D. An update on the bridging factors connecting autophagy and Nrf2 antioxidant pathway. Front Cell Dev Biol. 2023;11:1232241.","journal-title":"Front Cell Dev Biol"},{"key":"2123_CR47","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/jnc.15327","volume":"158","author":"CA Butler","year":"2021","unstructured":"Butler CA, Popescu AS, Kitchener EJA, Allendorf DH, Puigdell\u00edvol M, Brown GC. Microglial phagocytosis of neurons in neurodegeneration, and its regulation. J Neurochem. 2021;158:621\u201339. https:\/\/doi.org\/10.1111\/jnc.15327","journal-title":"J Neurochem"},{"key":"2123_CR48","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fimmu.2019.00790","volume":"10","author":"DA Galloway","year":"2019","unstructured":"Galloway DA, Phillips AE, Owen DR, Moore CS. Phagocytosis in the brain: homeostasis and disease. Front Immunol. 2019;10:790.","journal-title":"Front Immunol"},{"key":"2123_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","volume":"59","author":"RN Saunders","year":"2001","unstructured":"Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of the evidence. Kidney Int. 2001;59:3\u201316. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00460.x","journal-title":"Kidney Int"},{"key":"2123_CR50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1021\/cn100109k","volume":"2","author":"JW Chambers","year":"2011","unstructured":"Chambers JW, Pachori A, Howard S, Ganno M, Hansen D Jr., Kamenecka T, et al. Small molecule c-jun-N-terminal kinase (JNK) inhibitors protect dopaminergic neurons in a model of Parkinson\u2019s disease. ACS Chem Neurosci. 2011;2:198\u2013206. https:\/\/doi.org\/10.1021\/cn100109k","journal-title":"ACS Chem Neurosci"},{"key":"2123_CR51","doi-asserted-by":"publisher","first-page":"9416","DOI":"10.1021\/jm301020q","volume":"55","author":"AA Estrada","year":"2012","unstructured":"Estrada AA, Liu X, Baker-Glenn C, Beresford A, Burdick DJ, Chambers M, et al. Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem. 2012;55:9416\u201333. https:\/\/doi.org\/10.1021\/jm301020q","journal-title":"J Med Chem"},{"key":"2123_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","volume":"47","author":"S Matsuda","year":"2000","unstructured":"Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology. 2000;47:119\u201325. https:\/\/doi.org\/10.1016\/S0162-3109(00)00192-2","journal-title":"Immunopharmacology"},{"key":"2123_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1124\/mol.110.068064","volume":"79","author":"N Matsunaga","year":"2011","unstructured":"Matsunaga N, Tsuchimori N, Matsumoto T, Ii M. TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharm. 2011;79:34\u201341. https:\/\/doi.org\/10.1124\/mol.110.068064","journal-title":"Mol Pharm"},{"key":"2123_CR54","doi-asserted-by":"publisher","unstructured":"Lamming DW. Inhibition of the mechanistic target of rapamycin (mTOR)-rapamycin and beyond. Cold Spring Harb Perspect Med. 2016. https:\/\/doi.org\/10.1101\/cshperspect.a025924","DOI":"10.1101\/cshperspect.a025924"},{"key":"2123_CR55","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbi.2011.12.002","volume":"26","author":"G Krabbe","year":"2012","unstructured":"Krabbe G, Matyash V, Pannasch U, Mamer L, Boddeke HW, Kettenmann H. Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity. Brain Behav Immun. 2012;26:419\u201328.","journal-title":"Brain Behav Immun"},{"key":"2123_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fncel.2018.00309","volume":"12","author":"Y Fan","year":"2018","unstructured":"Fan Y, Chen Z, Pathak JL, Carneiro AM, Chung CY. Differential regulation of adhesion and phagocytosis of resting and activated microglia by dopamine. Front Cell Neurosci. 2018;12:309.","journal-title":"Front Cell Neurosci"},{"key":"2123_CR57","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1038\/s41380-023-02048-5","volume":"28","author":"G Albertini","year":"2023","unstructured":"Albertini G, D\u2019andrea I, Druart M, B\u00e9chade C, Nieves-Rivera N, Etienne F, et al. Serotonin sensing by microglia conditions the proper development of neuronal circuits and of social and adaptive skills. Mol Psychiatry. 2023;28:2328\u201342.","journal-title":"Mol Psychiatry"},{"key":"2123_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0797-6","volume":"14","author":"M-T Yang","year":"2017","unstructured":"Yang M-T, Lin Y-C, Ho W-H, Liu C-L, Lee W-T. Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures. J Neuroinflammation. 2017;14:15 https:\/\/doi.org\/10.1186\/s12974-017-0797-6","journal-title":"J Neuroinflammation"},{"key":"2123_CR59","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1096\/fj.201600495R","volume":"30","author":"D Li","year":"2016","unstructured":"Li D, Wang C, Yao Y, Chen L, Liu G, Zhang R, et al. mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type. FASEB J. 2016;30:3388\u201399.","journal-title":"FASEB J"},{"key":"2123_CR60","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","journal-title":"Nat Rev Neurol"},{"key":"2123_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","volume":"42","author":"A Monji","year":"2013","unstructured":"Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuro Psychopharmacol Biol Psychiatry. 2013;42:115\u201321. https:\/\/doi.org\/10.1016\/j.pnpbp.2011.12.002","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"2123_CR62","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fpsyt.2020.00071","volume":"11","author":"F Benedetti","year":"2020","unstructured":"Benedetti F, Aggio V, Pratesi ML, Greco G, Furlan R. Neuroinflammation in bipolar depression. Front Psychiatry. 2020;11:71.","journal-title":"Front Psychiatry"},{"key":"2123_CR63","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.3390\/jcm9113682","volume":"9","author":"MJ Brownstein","year":"2020","unstructured":"Brownstein MJ, Simon NG, Long JD, Yankey J, Maibach HT, Cudkowicz M, et al. Safety and tolerability of SRX246, a vasopressin 1a antagonist, in irritable Huntington\u2019s disease patients\u2014a randomized phase 2 clinical trial. J Clin Med. 2020;9:3682.","journal-title":"J Clin Med"},{"key":"2123_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55923-8","volume":"14","author":"N Chang","year":"2024","unstructured":"Chang N, Li J, Lin S, Zhang J, Zeng W, Ma G, et al. Emerging roles of SIRT1 activator, SRT2104, in disease treatment. Sci Rep. 2024;14:5521 https:\/\/doi.org\/10.1038\/s41598-024-55923-8","journal-title":"Sci Rep"},{"key":"2123_CR65","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fnins.2020.00444","volume":"14","author":"W Cui","year":"2020","unstructured":"Cui W, Sun C, Ma Y, Wang S, Wang X, Zhang Y. Inhibition of TLR4 induces M2 microglial polarization and provides neuroprotection via the NLRP3 inflammasome in Alzheimer\u2019s disease. Front Neurosci. 2020;14:444.","journal-title":"Front Neurosci"},{"key":"2123_CR66","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","volume":"38","author":"TW Rice","year":"2010","unstructured":"Rice TW, Wheeler AP, Bernard GR, Vincent J-L, Angus DC, Aikawa N, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*. Crit Care Med. 2010;38:1685\u201394. https:\/\/doi.org\/10.1097\/CCM.0b013e3181e7c5c9","journal-title":"Crit Care Med"},{"key":"2123_CR67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13045-020-00977-0","volume":"13","author":"L Huang","year":"2020","unstructured":"Huang L, Jiang S, Shi Y. Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001\u20132020). J Hematol Oncol. 2020;13:143 https:\/\/doi.org\/10.1186\/s13045-020-00977-0","journal-title":"J Hematol Oncol"},{"key":"2123_CR68","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ctrv.2015.04.003","volume":"43","author":"M Duvic","year":"2016","unstructured":"Duvic M, Dimopoulos M. The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: a review of clinical studies. Cancer Treat Rev. 2016;43:58\u201366. https:\/\/doi.org\/10.1016\/j.ctrv.2015.04.003","journal-title":"Cancer Treat Rev"},{"key":"2123_CR69","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12017-021-08660-4","volume":"23","author":"K Athira","year":"2021","unstructured":"Athira K, Sadanandan P, Chakravarty S. Repurposing vorinostat for the treatment of disorders affecting brain. Neuromolecular Med. 2021;23:449\u201365.","journal-title":"Neuromolecular Med"},{"key":"2123_CR70","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-neuro-110920-023056","volume":"45","author":"JR Lukens","year":"2022","unstructured":"Lukens JR, Eyo UB. Microglia and neurodevelopmental disorders. Annu Rev Neurosci. 2022;45:425\u201345. https:\/\/doi.org\/10.1146\/annurev-neuro-110920-023056.","journal-title":"Annu Rev Neurosci"},{"key":"2123_CR71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/neuroglia5020009","volume":"5","author":"VA Furlan","year":"2024","unstructured":"Furlan VA, MacAuslan D, Ha K, Patel N, Adam S, Zanagar B, et al. Microglial dyshomeostasis: a common substrate in neurodevelopmental and neurodegenerative diseases. Neuroglia. 2024;5:119\u201328.","journal-title":"Neuroglia"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02123-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:37:03Z","timestamp":1757169423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02123-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2123"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02123-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.23.630139","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RHP has received personal fees from Circular Genomics and Genomind, unrelated to the work described. He holds equity in Psy Therapeutics and Circular Genomics, unrelated to the work described, and is a paid editor at JAMA\u2009+\u2009AI and AI editor at JAMA Network-Open. The other authors have declared no competing financial interests in relation to the work described. A preprint of this study was submitted to bioRxiv (\n                      \n                      ) during submission before review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}